Patient Education Resource: Non-Hodgkin Lymphoma — Clinical Experts Address Common Questions Posed by Patients About CAR T-Cell Therapy
Échec de l'ajout au panier.
Veuillez réessayer plus tard
Échec de l'ajout à la liste d'envies.
Veuillez réessayer plus tard
Échec de la suppression de la liste d’envies.
Veuillez réessayer plus tard
Échec du suivi du balado
Ne plus suivre le balado a échoué
Patient Education Resource: Non-Hodgkin Lymphoma — Clinical Experts Address Common Questions Posed by Patients About CAR T-Cell Therapy
-
Narrateur(s):
-
Auteur(s):
À propos de cet audio
Featuring perspectives from Dr Jeremy S Abramson and Dr Manali Kamdar, including the following topics:
- Introduction: About This Program (0:00)
- Overview of Chimeric Antigen Receptor (CAR) T-Cell Therapy (3:10)
- Potential Treatment Benefits of CAR T-Cell Therapy (10:35)
- CRS (Cytokine Release Syndrome) and ICANS (Immune Effector Cell-Associated Neurotoxicity Syndrome) (34:32)
- Finding Information About CAR T; Clinical Trials (42:17)
- Financial Issues; Risk of Infection (48:11)
- Coping with Anxiety; Healing and Moving On (55:17)
Educational and presenter information
Pas encore de commentaire